INTRODUCTION
Human platelets rapidly incorporate radioactive phosphate, acetate, and glycerol into phospholipids (1) (2) (3) . Phosphatidylinositol represents a small fraction of the phospholipids labeled with acetate and palmitate (2) , but it is a significant proportion of the phospholipids labeled with glycerol (3) . Moreover, in experiments using radioactive phosphate, phosphatidylinositol is intensely labeled both in vivo and in vitro (1) . A selective increase in radioactive phosphate incorporation into phosphatidic acid and phosphatidylinositol occurs in leukocytes during phagocytosis as well as in a number of cells during secretion (4) (5) (6) (7) (8) . These data suggest that phosphatidylinositol production may be important in membrane integrity and function.
Previous work in this laboratory has demonstrated that human platelets can synthesize cytidine diphosphate diglyceride (CDP diglyceride) from cytidine triphosphate and phosphatidic acid (9) . When myoinositol was present during this reaction, CDP diglyceride accumulation decreased, and myoinositol-14C was incorporated into a chloroform-soluble product. This suggested that CDP diglyceride was the precursor of a lipid containing myoinositol. Several laboratories (10) (11) (12) have shown that the synthesis of phosphatidylinositol can occur by the following reaction: CDP diglyceride + myoinositol -> phosphatidylinositol + cytidine monophosphate (CMP). The studies reported in this paper demonstrate that human platelets contain the enzyme CDP-diglyceride: myoinositol, phosphatidyl transferase and characterize its properties.
METHODS

Separation of blood cells and preparation of homogenates.
Human platelets were prepared and washed as previously described (9) . Platelets, leukocytes, and erythrocytes were counted by routine techniques (13, 14) .
Platelet pellets were resuspended to an estimated count of 2 X 109/ml in 0.25 M sucrose containing 10' M NaEDTA and 10' M 2-mercaptoethanol adjusted to pH 7.0 with NaOH (subsequently referred to as buffered 0.25 M sucrose). The platelet suspension was frozen (solid C02) and thawed six times, and the disrupted platelets were used as the enzyme source in most of the experiments.
Polymorphonuclear (PMN) leukocytes, lymphocytes, and erythrocytes were obtained from fresh whole blood anticoagulated with heparin, using methods which minimize platelet contamination, and they were processed as previously described (9) . Except where indicated, all disrupted cells were stored at -20'C for no longer than 2 wk before they were assayed for enzymatic activity.
Preparation of CDP diglyceride. Phosphatidic acid was prepared from hen egg yolks, and it was reacted with cytidine-5'-monophosphomorpholidate in anhydrous pyridine to produce CDP diglyceride (15) . The CDP diglyceride was purified by silicic acid chromatography and stored as the ammonium salt in aqueous solution at -200C (9). The cytidine: phosphorus: ester molar ratio was 1.0: 2.16: 2.0, and two thin-layer chromatographic systems showed one spot (9) . Preparation of phosphatidylinositol. Isolation of phosphatidylinositol was initiated by aluminum oxide chromatography of a lipid extract of peas (16) . Phosphatidylinositol was eluted with chloroform: methanol (1: 1, v/v) containing 12% HO. Chloroform and methanolic 0.15 N HCl were added in sufficient volume to yield two phases (17) . The lower chloroform phase containing the phospholipids was passed through a short cellulose column to remove amino acids (18) . Final purification was achieved by chromatography on silicic acid (19) . The phosphorus: ester: nitrogen molar ratio of the phosphatidylinositol was 1.0: 2.15: 0.03.
Thin-layer chromatograms on plates of silica gel (slurred in 1 mM Na2CO3) developed with chloroform: methanol: acetic acid: H20 (25: 15: 4: 2, v/v) showed one spot with an R, of 0.52 (20) . Two-dimensional thin-layer chromatograms on plates of Silica Gel G developed with chloroform: methanol: H20 (65: 25: 4, v/v) and diisobutylketone: acetic acid: H20 (80: 50: 10, v/v) showed a single spot with respective R, values of 0.26 and 0.1 (21) .
Following deacylation of the phosphatidylinositol with methanolic NaOH (22) , 96% of the phosphate was recovered in the aqueous extract. The water-soluble product was iden- Product identification. A reaction mixture identical with that described in Fig. 1 , except that it contained 1 mM myoinositol-2-8H (SA 7.5 Ci/mole) and 1.2 mg of platelet protein in a final volume of 1.0 ml, was incubated at 370C for 60 min. Phosphatidylinositol 0.1 mmole was added at the end of the incubation period, and a chloroform extraction was performed as outlined in the Methods section, except that the volumes were doubled. The chloroform phase was taken to dryness under a stream of nitrogen, the residue was suspended in chloroform, and aliquots were used for thin-layer chromatography and hydrolysis.
The chloroform extract was examined for phosphatidylinositol by thin-layer chromatography as described in the Methods section. The lipids were eluted from the gel (20) , and the radioactivity was determined as previously described (9) . In two experiments 88% and 93% of the radioactivity migrated with the phosphatidylinositol spot. The remaining radioactivity trailed the phosphatidylinositol spot slightly in both systems, probably representing incomplete migration of the lipid.
An aliquot of the chloroform extract was taken to dryness, and the residue hydrolyzed in methanolic NaOH for 10 min at 370C (22) . After deacylation, the watersoluble products (containing 98% of the radioactivity) were examined by descending paper chromatography, using phenol: H20 (4:1, w/v) as the solvent, and ascending chromatography, using n-propanol: NH40H: H20 (5: 4: 1, v/v) as the solvent (25, 26) . Inositol phosphate, myoinositol, and GPI had respective Rf values of 0.05, 0.25, and 0.1 in the phenol: H20 system, and 0.35, 0.5, and 0.6 in the n-propanol: NH4OH: H20 system. 95% of the water-soluble radioactivity after alkaline hydrolysis migrated with GPI in both systems.
The lipid formed in the reaction mixture was also hydrolyzed in 2 N HCl (19) . The hydrolysis products were chromatographed on paper using the same two solvent systems. In both systems 80% of the radioactivity migrated as inositol phosphate and 15% as myoinositol; this agrees well with the data obtained by Hanahan and Olley using phosphatidylinositol isolated from beef liver (19) .
Time course. The rate of formation of phosphatidylinositol was not linear over the time interval investigated (Fig. 1) . 60 min was chosen as the incubation period for the remainder of the experiments.
Enzyme concentration. The enzymatic activity varied directly with the protein concentration of the disrupted platelets up to 0.7 mg/0.5 ml of reaction mixture. At higher protein concentrations the reaction rate deviated from linearity.
pH optimum and effect of buffer salts. The enzyme was active over a wide range of pH (6.3-10.6) with an optimal activity at pH 8.5-9.0 in 0.08 M Tris-HCl (Fig. 2) . Variation of the concentration of Tris-HCl from 0.04 to 0.32 M had no effect on phosphatidylinositol synthesis, but lower concentrations buffered the reaction poorly with resultant loss of enzyme activity. Boric acid-NaOH and phosphate buffers both at 0.08 M caused 60% and 34% inhibition of enzyme activity respectively (not illustrated).
Substrate and cofactors. In the absence of CDP diglyceride, divalent cation, or enzyme there was no significant production of phosphatidylinositol (Table I ). The affinity of the enzyme for CDP diglyceride is shown in Fig. 3 . The Km for CDP diglyceride was 0.53 mm when calculated from a Lineweaver-Burk plot of the reciprocal of the velocity vs. the reciprocal of the substrate concentration, but it appears to be about 0.2 mm from the plot of the reaction rate against substrate concentration. The Km of the enzyme for myoinositol was 0.27 mm when the CDP diglyceride concentration was 0.92 mm (Fig. 4) . Here the Km estimated from the plot of the reaction rate against substrate concentration agreed with that calculated from the Lineweaver-Burk plot. The velocity of the reaction using 3.6 mm myoinositol was approximately 85% of that achieved using myoinositol concentrations up to 10 mM. 
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ID is 2D COPD (mM) FIGURE 3 The production of phosphatidylinositol at varying concentrations of CDP diglyceride (CDPD). The conditions were identical with those detailed in Fig. 1 except that the CDP diglyceride concentration was varied as indicated, and the time of incubation was 60 min. inositol production. MgCl2 could be substituted for MnCI2 but was less effective. CDP diglyceride production with 4 mM and 40 mm MgCla was only 50% and 85% of that achieved with 4 mm MnCls. CaC12, CUSO4, and ZnSOt, all at 4 mm, caused no significant increase in enzymatic activity. 4 mm CaCl2, in the presence of 4 mm MnCl, produced a 33% decrease in enzymatic activity.
The addition of thiols increased enzymatic activity. In the absence of Na2EDTA, 4 mm, 10 mm, and 20 mM 2-mercaptoethanol increased phosphatidylinositol production to 250, 330, and 340%, respectively. 0.5 mm and 1.0 mM glutathione increased production to 112% and 136%, respectively.
In the absence of added 2-mercaptoethanol parachloromercuribenzoate (PCMB) 0.1 mm and 0.5 mm decreased enzyme activity by 58% and 97%. 1.25 mm and 10 mM iodoacetate caused 32% and 70% inhibition of enzyme activity in the absence of 2-mercaptoethanol. 2-mercaptoethanol reversed most of the inhibition produced by both PCMB and iodoacetate.
In the absence of 2-mercaptoethanol Na2EDTA 0.4 mm increased enzymatic activity by 40%. This concentration of Na2EDTA had no effect in the presence of 4.0 mm 2-mercaptoethanol. Na2EDTA concentrations higher than 1 mm were inhibitory.
Temperature effects. The production of phosphatidylinositol was investigated at 4, 25, 37, 50, and 600C. The enzyme activity was greatest at 370C, and all other experiments reported were performed at this temperature. When disrupted platelets were heated to 1000C for 5 min, all enzyme activity was lost. Storage of the disrupted platelets at 4VC for 7 days resulted in a 95% loss of enzyme activity. Storage of -20'C resulted in no loss of activity after 7 days, but there was a 40% decrease in activity after 1 month.
Miscellaneous observations. There was no marked inhibition of the reaction by addition of either of the reaction products. 3.3 mm and 6.6 mm CMP produced an 11% and a 26% decrease in phosphatidylinositol production. 0.1 mM, 0.4 mm, and 2.0 mm phosphatidylinositol caused, respectively, an 8%, 12%, and 20% decrease in the reaction rate.
The enzymatic activity was not increased by several detergents. Tween-80 0.1 mg/ml and Trition X-100 2 mg/ml had no significant effect on phosphatidylinositol production. Tween-80 1 mg/ml, sodium cholate 4 mg/ ml, and Cutscum 2.5 mg/ml, respectively, caused 29%, 29%, and 88% inhibition of enzyme activity. The studies with sodium cholate and Cutscum were complicated by incomplete removal of myoinositol-2-'H from the chloroform extract, and the phosphatidylinositol production was corrected by appropriate controls.
Attempts to solubilize the enzymatic activity by sonication or by treating the platelet particles with organic solvents or detergents was unsuccessful. Precipitation of the platelet particles with acetone or methanol: H20 (2: 1, v/v) resulted in more than 90% loss of enzyme activity.
0.1 M NaCl, 0.04 M KCI, 0.04 M NH4Cl, and 1 mm and 4 mM potassium fluoride had no effect on the reaction rate. Albumin 0.4 mg/ml and 2.0 mg/ml decreased phosphatidylinositol production by 2.5% and 21%.
Enzymatic activity in platelet subcellular fractions. Washed platelet pellets were homogenized as described by Marcus, Zucker-Franklin, Safier, and Ullman (27) , and fractionated by differential centrifugation as previously described (p). A similar homogenate was used to prepare "membranes" and "granules," as described by Myoinositol OM) FIGURE 4 The production of phosphatidylinositol at varying concentrations of myoinositol. The conditions were identical with those detailed in Fig. 1 except that the myoinositol concentration was varied as indicated (SA 2.1 Ci/mole when myoinositol concentrations were 0.125-0.5 mm and 0.7 Ci/ mole when concentrations were 1.5-10 mM). The time of incubation was 60 min.
Marcus et al. (subcellular fractions were not examined by electron microscopy). The platelet subcellular fractions were washed once and resuspended in sufficient buffered 0.25 M sucrose to make the final protein concentration 1-2 mg/ml. The 100,000 g pellet and the "membranes" contained the greatest specific activity (Table II) Enzymatic activity in platelets from normal subjects and patients. Platelets from 12 normal subjects disrupted by repeated freezing and thawing (protein concentration 1.2-2.4 mg/ml) catalyzed the production of 0.35-0.55 mtmole of phosphatidylinositol per mg of protein per min. The platelets of five uremic patients (blood urea nitrogen greater than 90 mg/100 ml), two patients with polycythemia vera, and one patient with Glanzmann's thrombasthenia had enzymatic activity in the same range. $ These subcellular fractions were isolated on continuous sucrose gradients as described by Marcus, Zucker-Franklin, Safier, and Ullman (27) .
DISCUSSION
The incorporation of myoinositol into phosphatidylinositol was first demonstrated by Agranoff, Bradley, and Brady using guinea pig kidney mitochondria (28 (30) and remain unexplained. The Km of 0.53 mM for CDP diglyceride is similar to those reported for guinea pig pancreas microsomes and brain microsomes when CDP-dipalmitin was used as a substrate. The fatty acid composition of the CDP diglyceride used in these experiments was not determined. Since it was synthesized from hen egg phosphatidylcholine, it would be expected to be a mixture of highly unsaturated, longchained fatty acids (31, 32). The Km might be different for CDP diglyceride with specific fatty acid composition. Benjamins and Agranoff have demonstrated this phenomenon in guinea pig brain microsomes (12) . Similar considerations apply to the specific activity of the enzyme as discussed below. The Km of the enzyme for myoinositol is 0.27 mm, a value close to the Km for myoinositol (0.2 mM) found for the enzyme present in chicken liver microsomes, but distinctly less than the Km of the enzyme (1.5 mM) in brain and pancreas microsomes. The pH optimum of 8.5-9.0 is slightly higher than that described for the enzyme in other mammalian tissues (pH 7.5-8.6). The enzyme in platelet "membranes" has a specific activity which is about one-half the specific activity of the enzyme in pancreas microsomes, and only 6% of the specific activity of the enzyme in guinea pig brain microsomes. The high specific activity in brain microsomes is partially due to the use of the substrate CDP-didecanoin, for which the enzyme has a faster reaction rate and a lower Km (1.7 X 10-4 M) than the other CDP diglycerides (12) . The marked effect of thiol compounds and sulfhydryl-binding agents on the enzymatic activity in platelets has not been demonstrated in other mammalian tissues.
We have previously demonstrated that platelets can synthesize CDP diglyceride from phosphatidic acid and cytidine triphosphate. The enzyme characterized in this report could then convert the CDP diglyceride to phosphatidylinositol. These data provide further evidence that the rapid incorporation of radioactive phosphorus into phosphatidylinositol represents synthesis of this phospholipid at least in part and is not due solely to an exchange phenomenon. The activity of the enzyme was normal in platelets from patients with diseases known to be characterized by abnormal platelet function (uremia, polycythemia, Glanzmann's thrombasthenia). The role of this biosynthetic pathway in platelet metabolism remains to be elucidated.
